By Our Editor
There is a growing rush across Nigeria for a newly introduced HIV prevention injection, as many citizens scramble to access the drug ahead of its nationwide rollout.
The injection, known as Lenacapavir, is a long-acting HIV prevention medication that is administered twice a year, offering an alternative to daily pills.
Findings show that Nigerians, especially those already aware of HIV prevention methods, have been approaching hospitals and health organisations in large numbers to secure the injection.
The development follows the Federal Government’s move to begin distribution of the drug in selected states as part of a pilot programme.
Health authorities confirmed that Nigeria has already received thousands of doses, with more expected as part of a broader rollout plan.
Lenacapavir has been described as a major breakthrough in HIV prevention, as it reduces the need for daily medication and improves adherence among users.
The drug has also gained global attention after it was recommended by international health bodies as an effective option for preventing HIV infection.
Reports indicate that the injection will first be introduced in selected states including Lagos, Abuja, and others before expanding nationwide.
Health officials say the rollout is part of efforts to reduce new HIV infections and strengthen Nigeria’s response to the disease, which still affects millions of people in the country.
With rising awareness and demand, experts believe the success of the programme will depend on accessibility, proper distribution, and sustained public education.